# Archived Documentation

**Status:** SUPERSEDED  
**Date Archived:** December 23, 2025

---

## Notice

All documents in this folder have been superseded by the **Phase 4 Master Benchmark Report**:

ðŸ“„ **Current Master Document:** `../PHASE_4_MASTER_BENCHMARK_REPORT.md`

---

## Archived Files

These documents are kept for historical reference only:

| File | Original Purpose | Superseded By |
|------|------------------|---------------|
| COMPLETE_ACCOMPLISHMENT_REPORT.md | Phase 3 accomplishments | Phase 4 Master Report |
| DATA_ENRICHMENT_REPORT.md | Data pipeline details | Phase 4 Master Report |
| DATA_PIPELINE_COMPLETION_SUMMARY.md | Pipeline completion | Phase 4 Master Report |
| FINAL_320_STUDY_REPORT.md | 320-study milestone | Now 368 studies in Phase 4 |
| GENEPATH_DATASET_COMPLETION_REPORT.md | GenePath dataset | Phase 4 Master Report |
| PHASE_3_COMPLETION_REPORT.md | Phase 3 summary | Phase 4 Master Report |
| PHASE_4_DAY_2_TRAINING_SUMMARY.md | Day 2 training | Phase 4 Master Report |
| PHASE_4_DAY_3_CHEMICAL_INTEGRATION.md | Day 3 chemistry | Phase 4 Master Report |
| PHASE_4_DAY_3_COMPLETE_REPORT.md | Day 3 summary | Phase 4 Master Report |
| TEST_DEBUGGING_COMPLETE.md | Test debugging | Phase 4 Master Report |
| THERAPEUTIC_MODEL_FIX_REPORT.md | Model fixes | Phase 4 Master Report |
| WEEK_13_COMPLETION_REPORT.md | Week 13 summary | Phase 4 Master Report |

---

## Do Not Reference

These documents contain **outdated metrics** (e.g., 320 studies instead of 368).

For current project status, always refer to:
- `PHASE_4_MASTER_BENCHMARK_REPORT.md`
- `TRADE_SECRET_IMPLEMENTATION_REPORT.md`
- `TRADE_SECRET_DATA_REQUIREMENTS.md`

---

*Cloak and Quill Research 501(c)(3)*
